StockData
Neuraxis, INC logo

Neuraxis, INC (NRXS) stock

NRXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 0/30
$4.61−0.19 (-3.96%)

Close on Nov 17, 2026Market cap $57.89MP/E –Yield –

Neuraxis gross margin

Gross margin is gross profit as a percentage of revenue.

Neuraxis's gross margin for the twelve months ending Jun 30, 2026 was 85.6%. For fiscal 2025 it was 84.2%, against 86.5% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202584.2%−2.3
FY2024Dec 31, 202486.5%−1.1
FY2023Dec 31, 202387.7%−1.3
FY2022Dec 31, 202288.9%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202685.9%+2.3
Q1 FY2026Mar 31, 202686.4%+2.0
Q4 FY2025Dec 31, 202585.4%−0.8
Q3 FY2025Sep 30, 202583.3%−2.1
Q2 FY2025Jun 30, 202583.6%−4.4
Q1 FY2025Mar 31, 202584.4%−4.0
Q4 FY2024Dec 31, 202486.2%−0.2
Q3 FY2024Sep 30, 202485.4%−0.5
Q2 FY2024Jun 30, 202488.0%−1.5
Q1 FY2024Mar 31, 202488.4%+0.3
Q4 FY2023Dec 31, 202386.4%−1.3
Q3 FY2023Sep 30, 202385.9%−3.2
Q2 FY2023Jun 30, 202389.5%+1.1
Q1 FY2023Mar 31, 202388.1%–
Q4 FY2022Dec 31, 202287.7%–
Q3 FY2022Sep 30, 202289.1%–
Q2 FY2022Jun 30, 202288.4%–

More Neuraxis figures

See a number that looks wrong?